Tots N Teens Clinics

Tots N Teens Clinics was paid $4.73M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 18% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	104	$2K
2019	337	$6K
2020	13,500	$295K
2021	55,669	$1.41M
2022	51,419	$959K
2023	59,656	$947K
2024incomplete	48,500	$1.11M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	18%	18,668	15,889	$829K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	21,468	18,107	$709K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	15%	5,335	4,584	$692K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	6.6%	5,320	4,746	$311K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	5.8%	5,641	4,727	$273K
90460	Immunization administration through 18 years of age via any route, first or only component	5.3%	26,694	11,519	$249K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	4.4%	3,306	3,016	$209K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	3.1%	2,035	1,893	$147K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	2.8%	10,553	9,552	$134K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	2.4%	7,223	3,380	$112K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	2.2%	2,587	2,366	$105K
87428		2.0%	1,923	1,755	$95K

74 more codes

92552		1.6%	3,428	$74K
99381		1.3%	1,335	$61K
99383		1.2%	878	$57K
69210		1.1%	1,541	$51K
90677		1.1%	1,189	$51K
99215	Doctor's office visit, returning patient (complex)	1.0%	665	$47K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	5,831	$45K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	107	$43K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	545	$35K
99000		<1%	3,469	$33K
99384		<1%	461	$32K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,512	$30K
99204	Doctor's office visit, new patient (more involved)	<1%	355	$29K
90461		<1%	14,784	$29K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	792	$29K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,013	$24K
90619		<1%	340	$20K
87807		<1%	1,942	$20K
99382		<1%	326	$19K
99203	Doctor's office visit, new patient (routine)	<1%	315	$18K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	2,828	$15K
83655		<1%	1,814	$13K
97802		<1%	4,153	$9K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	841	$9K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	743	$9K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	349	$8K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	378	$8K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	24	$7K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	371	$5K
96161		<1%	5,476	$4K
54450		<1%	81	$4K
95115		<1%	411	$3K
81002		<1%	814	$2K
99050		<1%	222	$2K
85018		<1%	1,286	$2K
90670		<1%	3,015	$2K
90651		<1%	1,118	$1K
92567		<1%	104	$1K
84030		<1%	492	$1K
90680		<1%	2,776	$980.21
90698		<1%	3,061	$967.75
90621		<1%	225	$879.09
36415	Collection of venous blood by venipuncture	<1%	2,584	$761.60
A7003	Administration set, with small volume nonfiltered pneumatic nebulizer, disposable	<1%	320	$752.50
90710		<1%	1,386	$735.03
94760		<1%	543	$488.77
90648		<1%	1,108	$361.20
90744		<1%	2,151	$306.05
90633		<1%	2,307	$301.05
94010		<1%	12	$289.68
90696		<1%	907	$280.00
90707		<1%	794	$262.53
90716		<1%	722	$262.52
90715		<1%	597	$189.48
96380		<1%	13	$171.82
90686		<1%	1,988	$146.72
90713		<1%	120	$120.30
90700		<1%	1,211	$108.07
69209		<1%	12	$77.47
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	271	$27.76
99173		<1%	6,190	$17.50
96160		<1%	13	$11.25
90734		<1%	514	$0.07
S3620	Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)	<1%	81	$0.03
90688		<1%	442	$0.01
99441		0%	32	$0.00
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	0%	31	$0.00
90381		0%	17	$0.00
96127		0%	120	$0.00
90656		0%	194	$0.00
A9150	Non-prescription drugs	0%	13	$0.00
99072		0%	21,277	$0.00
J7699	Noc drugs, inhalation solution administered through dme	0%	31	$0.00
90380		0%	21	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialABO KAYASS, AHMAD (OWNER)